Photo Credit – CDC
# 6853
Last Friday, in FluView Week 1 & MMWR Vaccine Effectiveness Report, we looked at the first estimate of this year’s flu vaccine’s effectiveness, and early numbers suggest it to be around 62%.
An estimate that is very close to what the 2011 study by Michael Osterholm and his team at CIDRAP - A Comprehensive Flu Vaccine Effectiveness Meta-Analysis - found; that most years the flu vaccine was `moderately’ protective.
Unfortunately for the elderly and for those with immune problems – the people most at risk of complications from the flu – the flu vaccine’s effectiveness is often even lower (see Study: Flu Vaccines And The Elderly).
Today the inimitable Helen Branswell, ace health reporter for The Canadian Press gives us a terrific look at the vaccine effectiveness issue, with interviews of Dr. Michael Osterholm of CIDRAP, Dr. Nancy Cox at the CDC, and Dr. Danuta Skowronski of the B.C. Centre for Disease Control, and Dr. Edward Belongia of the Marshfield Clinic in Marshfield, Wisconsin.
At this point, I’ll just step out of the way and invite you to read:
Flu studies suggest vaccine `match' not super predictor of effectiveness
Helen Branswell,
Sunday, January 13, 2013 7:55 PM
Highly Recommended.
Related Post:
- mBio: Coronavirus Has An Affinity For Multiple Hosts
- Branswell On Expanded Surveillance For The Coronavirus
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- SARS Virus Placed On Select Agents List
- Branswell Updates The Novel Coronavirus Story
- Osterholm: Time To Close The Pig Barns
- Branswell On Lifting The H5N1 Research Moratorium
- Pediatrics: Low Uptake Of Flu Vaccine Among Toddlers In Ontario
- NSABB Clears H5N1 Studies For Publication
- NSABB To Re-examine H5N1 Research Risks
- Branswell: WHO Hopes H5N1 Studies Can Be Published By Summer
- Branswell On The Transmissibility Of The H3N2v Virus
- Branswell On the CFR Of H5N1
- Eurosurveillance: Older People May Be Susceptible To The H3N2v Virus
- WHO: Will Host H5N1 Talks In Geneva
- Branswell On The Research Moratorium
- Branswell: WHO on H5N1 Research Controversy
- Publish or Perish The Thought?
- Three Would Make For A Crowded Viral Field
- Branswell: PLoS One Study On Adverse Reactions To MMR Vaccine
- Branswell On The New trH3N2 Flu Virus
- CIDRAP: New Details In The trH3N2 Story
- Branswell On The WHO Response To trH3N2
- More Details On The trH3N2 Story
- Anticipating The Flu Season Down Under
- ACP Calls For Health Care Worker Immunizations
- Flu Vaccine Still Available, But Spot Shortages Exist
- What is Metoclopramide - Side Effects
- Combat the Stomach Flu Symptoms with Prochlorperazine
- CDC Statement On This Year’s Flu Activity
- HPA: Flu Activity In The UK
- Flu Reports From Around The Nation
- Stomach Flu Symptoms - Ugly Truth
- Stomach Flu - What to Eat!?
- FluView, FluWatch, And WHO Flu Surveillance Reports
- Lancet: Low Flu Vaccine Effectiveness
- Early Flu Cases Begin To Emerge
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- Rhode Island Adopts New Flu Vaccination Requirements For HCPs
- Lancet: Public Response To The H1N1 Pandemic Of 2009
- A WHO Flu Review
- WHO: Southern Hemisphere 2013 Flu Vaccine Composition
- FluView Week 37 & Variant Flu Update
- NPM12: Giving Preparedness A Shot In The Arm
- The Return Of H1N1v
- CDC Variant Flu Update & FluView Week 35
- Osterholm: Time To Close The Pig Barns
- EID Journal: Flu In Healthy-Looking Pigs
Widget by [ Iptek-4u ]